Quentin CasaresData and AI leadership for regulated growth
Products and services

Fixed-scope diagnostic

Executive data & AI confidence review

A ten-business-day independent review of whether the organisation's data, reporting, governance, and AI controls can support the decisions now being asked of them.

A board-readable view of what is true, what is exposed, and what should happen over the next 90 days.

The problem

Start with the decision failure, not the technology label.

Senior leaders often sense that reporting, data ownership, platform decisions, or AI adoption are not yet defensible, but lack a fast and independent way to separate symptoms from root causes.

What changes

  • A shared executive view of the decision and control risks that matter now.
  • A prioritised distinction between urgent remediation and strategic architecture work.
  • A credible 30, 60, and 90-day sequence with named ownership.
  • A clear basis for a board decision, investment case, remediation programme, or leadership mandate.

Scope

Concrete artefacts, not advisory fog.

The scope is deliberately explicit so the buyer knows what will exist at the end of the engagement or product implementation.

01

Executive interviews and evidence request

02

Data, reporting, governance, and AI maturity assessment

03

Risk and opportunity heatmap

04

Decision and control dependency map

05

90-day action plan

06

Board-ready findings pack and executive readout

Method

A short sequence that ends in ownership and a decision.

Each stage has a purpose, an evidence expectation, and a defined hand-off.

  1. 01

    Frame

    Agree the board, regulatory, commercial, or transaction decision at stake and the evidence required to support it.

  2. 02

    Inspect

    Review selected artefacts and interview the leaders accountable for data, finance, risk, technology, and AI use.

  3. 03

    Diagnose

    Test operating reality against ownership, traceability, control, delivery, and decision-quality criteria.

  4. 04

    Decide

    Present the heatmap, trade-offs, and 90-day sequence in a concise executive readout.

Strong fit

  • The board does not fully trust a critical report or metric.
  • AI adoption is moving faster than accountability and evidence.
  • A new CFO, CDO, CRO, or investor needs an independent baseline.
  • A major platform, remediation, or operating-model decision is approaching.

Boundaries

  • This is a diagnostic, not a disguised multi-month implementation sale.
  • The review depends on timely access to a small, agreed evidence set and executive stakeholders.
  • Legal opinions, formal audit assurance, and penetration testing remain with qualified specialists.

Next step

The first conversation should test fit, not manufacture urgency.

Bring the live decision, deadline, evidence gap, and stakeholder context. You will get a direct view on whether this offer is the right intervention.